A recent study from Chapel Hill, NC, shows some bloodstream infections are reduced by nearly 50% when trained nurse observers assist catheter insertion teams.
A recent report published in the American Journal of Infection Control (AJIC) suggests that creating a dedicated team of nurses to assist with central line insertions can significantly reduce the risk of patients developing bloodstream infections. The report, authored by infection preventionists at UNC Health, shows that implementing a dedicated team led to a 47% reduction in the proportion of central line-associated bloodstream infections (CLABSIs) occurring within 7 days of line placement among patients included in the program.
To examine the report’s results, Infection Control Today® (ICT®) spoke with Shelley Summerlin-Long, MPH, MSW, BSN, RN, senior quality improvement leader, infection prevention, UNC Medical Center, Chapel Hill, North Carolina. The team was launched in 2019 with 4.5 fulltime employees to cover 24-hour, 7-day-a-week clinical coverage.
The team’s “key finding was during the team's first 3 years [from] 2019 to 2022, we found that CLABSIs that were occurring during those first 6 days after central line insertions decreased by 47% in the areas within that team’s scope,” Summerlin said.
“They play an important role during the insertion process,” Summerlin continued. “They are there to [provide] support. The evidence-based guidelines for CLABSI prevention recommend having a second person, a trained health care provider in the room during central line insertions who is empowered to stop the procedure, if there are any breaches in aseptic technique and who is there to document on the checklist, and in general, support the provider who is inserting the central lines. Our central venous access device (CVAD) Liaison team is there to help set up the room to document on the checklist, again, to observe the aseptic technique, help the provider if there are any issues that come up, and then go get additional supplies if needed. And they're experts in this and able to guide that the provider and especially helpful for our learners, our residents.”
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.